McKesson (NYSE:MCK) Trading Up 0%

Shares of McKesson Co. (NYSE:MCK - Get Free Report) traded up 0% during mid-day trading on Monday . The company traded as high as $566.16 and last traded at $564.62. 147,601 shares were traded during mid-day trading, a decline of 79% from the average session volume of 705,185 shares. The stock had previously closed at $564.52.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. TD Cowen boosted their price objective on shares of McKesson from $563.00 to $652.00 and gave the company a "buy" rating in a research report on Wednesday, May 8th. StockNews.com upgraded shares of McKesson from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 4th. Robert W. Baird boosted their price target on shares of McKesson from $603.00 to $671.00 and gave the company an "outperform" rating in a research report on Wednesday, May 8th. SVB Leerink began coverage on shares of McKesson in a research report on Monday, February 26th. They set an "outperform" rating and a $600.00 price target on the stock. Finally, Morgan Stanley boosted their price target on shares of McKesson from $522.00 to $548.00 and gave the company an "overweight" rating in a research report on Monday, April 15th. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, McKesson has an average rating of "Moderate Buy" and a consensus target price of $571.47.

McKesson Stock Down 0.1 %

The stock's fifty day simple moving average is $535.61 and its two-hundred day simple moving average is $499.56. The firm has a market cap of $73.32 billion, a PE ratio of 25.20, a PEG ratio of 1.33 and a beta of 0.45.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Tuesday, May 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.34 by ($0.16). The firm had revenue of $76.36 billion during the quarter, compared to the consensus estimate of $79.32 billion. McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The company's quarterly revenue was up 10.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.19 EPS. On average, equities research analysts anticipate that McKesson Co. will post 31.55 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be paid a $0.62 dividend. The ex-dividend date of this dividend is Monday, June 3rd. This represents a $2.48 annualized dividend and a dividend yield of 0.44%. McKesson's dividend payout ratio is presently 11.08%.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 3,473 shares of the company's stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the transaction, the chief executive officer now owns 43,445 shares in the company, valued at $22,789,074.75. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, CEO Brian S. Tyler sold 3,473 shares of the stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the transaction, the chief executive officer now owns 43,445 shares in the company, valued at $22,789,074.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Susan R. Salka sold 606 shares of the stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $558.04, for a total transaction of $338,172.24. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,080 shares of company stock worth $2,160,489. Corporate insiders own 0.21% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Strategic Wealth Partners Ltd. purchased a new stake in McKesson during the first quarter valued at approximately $308,000. Wahed Invest LLC increased its holdings in McKesson by 14.4% during the first quarter. Wahed Invest LLC now owns 2,609 shares of the company's stock valued at $1,401,000 after buying an additional 329 shares during the last quarter. Citizens Financial Group Inc. RI increased its holdings in McKesson by 3.7% during the first quarter. Citizens Financial Group Inc. RI now owns 985 shares of the company's stock valued at $529,000 after buying an additional 35 shares during the last quarter. Plato Investment Management Ltd increased its holdings in McKesson by 251.9% during the first quarter. Plato Investment Management Ltd now owns 3,463 shares of the company's stock valued at $1,859,000 after buying an additional 2,479 shares during the last quarter. Finally, KLCM Advisors Inc. increased its holdings in McKesson by 67.8% during the first quarter. KLCM Advisors Inc. now owns 1,057 shares of the company's stock valued at $568,000 after buying an additional 427 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.